» Articles » PMID: 23472781

Medical Therapy and Physical Maneuvers in the Treatment of the Vasovagal Syncope and Orthostatic Hypotension

Overview
Date 2013 Mar 12
PMID 23472781
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with vasovagal syncope and neurogenic orthostatic hypotension can both present with pre-syncope and syncope resulting from systemic hypotension. While not directly responsible for increased mortality, both of these conditions can have a tremendous deleterious impact on the daily lives of patients. This negative impact can take the form of both physical symptoms and injury, but also a psychological impact from living in fear of the next syncopal episode. Despite these similarities, these are different disorders with fixed damage to the autonomic nerves in neurogenic orthostatic hypotension, as opposed to a transient reflex hypotension in "neurally mediated" vasovagal syncope. The treatment approaches for both disorders are parallel. The first step is to educate the patient about the pathophysiology and prognosis of their disorder. Next, offending medications should be withdrawn when possible. Non-pharmacological therapies and maneuvers can be used, both in an effort to prevent the symptoms and to prevent syncope at the onset of presyncope. This is all that is required in many patients with vasovagal syncope. If needed, pharmacological options are also available for both vasovagal syncope and neurogenic orthostatic hypotension, many of which are focused on blood volume expansion, increasing cardiac venous return, or pressor agents to increase vascular tone. There is a paucity of high-quality clinical trial data to support the use of these pharmacological agents. We aim to review the literature on these different therapy choices and to give recommendations on tailored approaches to the treatment of these conditions.

Citing Articles

Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review.

Cuevas S, Mayer E, Hughes M, Adler B, McMahan Z J Scleroderma Relat Disord. 2025; 23971983241308050.

PMID: 39790996 PMC: 11707778. DOI: 10.1177/23971983241308050.


Vasovagal Syncope: A Review of Current and Emerging Therapies for a Common Cardiology Condition.

Tajdini M, Behnoush A, Khalaji A, Raj S J Tehran Heart Cent. 2024; 19(1):1-5.

PMID: 39712356 PMC: 11659707. DOI: 10.18502/jthc.v19i1.15529.


Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024).

Wang C, Liao Y, Wang S, Tian H, Huang M, Dong X World J Pediatr. 2024; 20(10):983-1002.

PMID: 39110332 PMC: 11502568. DOI: 10.1007/s12519-024-00819-w.


Analysis of hot trends in research on the association between vitamin D and cardiovascular disease.

Luo X, Wu F, Wang C, Wen C Front Nutr. 2023; 9:1073698.

PMID: 36712532 PMC: 9881723. DOI: 10.3389/fnut.2022.1073698.


Anxiety and Depression as Risk Factors for Vasovagal Syncope and Potential Treatment Targets: A Systematic Review.

Abuzainah B, Gutlapalli S, Chaudhuri D, Khan K, Al Shouli R, Allakky A Cureus. 2023; 14(12):e32793.

PMID: 36694488 PMC: 9858696. DOI: 10.7759/cureus.32793.


References
1.
Smit A, Wieling W, Fujimura J, Denq J, Opfer-Gehrking T, Akarriou M . Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004; 14(3):167-75. DOI: 10.1007/s10286-004-0187-x. View

2.
Lechner S, Markworth S, Poole K, Smith E, Lapatsina L, Frahm S . The molecular and cellular identity of peripheral osmoreceptors. Neuron. 2011; 69(2):332-44. DOI: 10.1016/j.neuron.2010.12.028. View

3.
Low P, Gilden J, Freeman R, Sheng K, McElligott M . Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA. 1997; 277(13):1046-51. View

4.
Freeman R, Wieling W, Axelrod F, Benditt D, Benarroch E, Biaggioni I . Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011; 21(2):69-72. DOI: 10.1007/s10286-011-0119-5. View

5.
Parry S, Matthews I . Update on the role of pacemaker therapy in vasovagal syncope and carotid sinus syndrome. Prog Cardiovasc Dis. 2013; 55(4):434-42. DOI: 10.1016/j.pcad.2012.10.012. View